PRPO — Precipio, Inc.

Nasdaq · Unknown · Unknown · CIK 1043961 ·
Last close
$22.10
Market Cap
$39.50M
52W High
$33.63
52W Low
$21.67
ADV30
33,610
Next earnings
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 6,711,000 2,725,000 -1,428,000 -1,443,000 20,803,000 2,604,000 6,636,000
Dec 2025 6,699,000 3,132,000 542,000 526,000 21,317,000 2,651,000 6,756,000
Sep 2025 6,767,000 3,005,000 -61,000 -79,000 21,153,000 2,305,000 7,404,000
Jun 2025 5,654,000 2,429,000 -824,000 74,000 18,816,000 1,130,000 6,528,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$793,000
Investing CF
$-238,000
Financing CF
$1,032,000
CapEx
$-238,000
Dividends Paid
Buybacks
EPS Diluted TTM
$-1.40
As of
2026-06-07

Balance + Analyst (yfinance extras)

Retained Earnings
$-104,246,000
Inventory
$870,000
Receivables
$1,988,000
ST Investments
EBIT TTM
$-859,000
Pretax Income TTM
$-922,000
Interest Exp TTM
$63,000
Analysts

Yahoo Snapshot (yfinance, live)

Total Revenue
$25,831,000
EBITDA
$-356,000
Free Cash Flow
$84,750
Enterprise Value
$40,388,920
Total Cash
$2,604,000
Total Debt
$3,492,000
Shares Out
1,787,372
Trailing EPS
$-0.45
Book Value
$7.94
ROE
-7.1%
ROA
-5.7%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 24,049,000 -363,000 21,317,000 6,756,000 685,000
Dec 2024 18,532,000 -4,290,000 16,996,000 4,902,000 439,000
Dec 2023 15,197,000 -5,853,000 18,101,000 3,672,000 -3,559,000
Dec 2022 9,412,000 -12,203,000 21,504,000 5,137,000 -7,721,000

TTM Snapshot

Revenues TTM
$11,485,000
NetIncome TTM
$-13,430,000
OpCashFlow TTM
$0
Assets (Latest)
$842,000
Forward EPS
$0.39

Peers — same industry

TickerNameMarket CapLastDaily %
RDEXF RPX Gold Inc. $39.46M $0.11
MAMO Massimo Group $39.56M $0.95
ISTKF Intellistake Technologies Corp. $39.42M $0.27
VTSI VirTra, Inc $39.35M $3.48
GAME GameSquare Holdings, Inc. $39.73M $0.42

News headlines (Yahoo Finance, 1h cache)

Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting
2026-06-12 17:00 · Yahoo
Precipio to Present at the Planet MicroCap Las Vegas
2026-06-11 21:00 · Yahoo
Precipio (PRPO) Q1 2026 Earnings Call Transcript
2026-06-02 16:54 · Yahoo
Precipio (PRPO) Q4 2025 Earnings Transcript
2026-06-02 16:15 · Yahoo
Precipio Stock Slips Post Q1 Earnings Despite Revenue Growth
2026-05-22 14:27 · Yahoo
Precipio Inc (PRPO) Q1 2026 Earnings Call Highlights: Revenue Growth Amidst Margin Challenges
2026-05-21 01:01 · Yahoo
Precipio Announces Q1 2026 Financial Results
2026-05-14 21:00 · Yahoo
Management team’s 2025 market-based Options have vested
2026-05-13 21:00 · Yahoo
The Zacks Analyst Blog NVIDIA, Mastercard, AbbVie, Waterstone and Precipio
2026-05-13 10:12 · Yahoo
Top Stock Reports for NVIDIA, Mastercard & AbbVie
2026-05-12 20:28 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.